The proportion of patients in molecular remission at different time periods (90, 180, 270, 360, 540, 720, 900, and 1080 days) after PBSCT, BMT, or CD34⁺-PBSCT from sibling donors.

░ represents BMT patients; ▪, PBSCT patients; and ■, CD34⁺-PBSCT patients. The number of evaluated patients was 71 at day 90 and 15 at day 1080.